2 Israeli pharmas get FDA thumbs-up
Gamida Cell wins orphan drug status for stem-cell treatment; cCam Biotherapeutics gets okay for clinical trial of antibody treatment for cancers.
Gamida Cell wins orphan drug status for stem-cell treatment; cCam Biotherapeutics gets okay for clinical trial of antibody treatment for cancers.
Collaboration to assist Israeli drug discovery company in further substantiating potential of its novel proteins as targets for cancer immunotherapy.
ISRAEL21c rounds up the top super-cool technological advances from Israeli companies that you should keep an eye on next year.